Behavioral health company Ontrak Inc. announced the loss of its second major customer this year.
A new cancer research institute has opened its doors on L.A.’s Westside.
Temple City-based genetic testing company Fulgent Genetics Inc. announced two deals with cancer testing companies.
In one of its largest cancer treatment practice acquisitions to date, Duarte-based cancer research institution City of Hope has acquired Long Beach-based Pacific Shores.
The founders of telehealth company Get Heal Inc. have raised $3.8 million in seed funding toward the launch of a new digital health venture.
The 2021-22 edition of U.S. News & World Report rankings put UCLA Medical Center in the No. 3 spot and Cedars-Sinai Medical Center in the No. 6 slot nationally.
ImmunityBio’s share price has headed almost entirely downhill, shedding 70% of its value in four months.
Biopharma company Kite will sell one of its drug platforms and a manufacturing facility in Maryland to BioNTech.
Uniper Care Technologies, a home-based senior services content provider headquartered in Tel Aviv, Israel, with its U.S. headquarters in Palms, has raised $14.5 million to expand its television-based platform in the United States.
Santa Monica-based immunotherapy company Kite, a subsidiary company of Foster City-based Gilead Sciences Inc., has signed one new drug development partnership and hit a key milestone with another.
Shares of Pasadena-based Arrowhead Pharmaceuticals Inc. plunged 34% on July 2 to $63.07 after the company halted trials of a drug to treat cystic fibrosis following reports of toxicity issues in tests of the drug on rats.
Incubators have long been viewed as crucial to jump-start the development of tech, life science and other companies.
Cerritos-based cancer treatment company Oncology Institute of Hope & Innovation announced that it intends to go public through a SPAC.
Marsh & McLennan Agency Survey: Tech Firms Re-imagine Employee Perks And Benefits In Response To The Pandemic
Tech companies are reacting to the post COVID-19 business environment by doing what they do best: Innovating to meet changing market dynamics.
Century City-based Vida Ventures, a life sciences investment fund co-founded by local biotech magnate and serial bioscience investor Arie Belldegrun, announced June 24 that it has closed its third fund after having raised $825 million from various institutional investors.